Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02454933
Title Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours (CAURAL)
Acronym CAURAL
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Busan 47392 Korea, Republic of Details
Research Site Daegu 42601 Korea, Republic of Details
Research Site Incheon 21565 Korea, Republic of Details
Research Site Jinju-si 660-702 Korea, Republic of Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 03181 Korea, Republic of Details
Research Site Seoul 156-707 Korea, Republic of Details
Research Site Ulsan 44033 Korea, Republic of Details
Research Site Kaohsiung 82445 Taiwan Details
Research Site Taichung 40705 Taiwan Details
Research Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field